The present study revealed for the first time that SERPING1 is regulated by sorafenib, which in turn reduces HCC cell migration might through the upregulation of p‐ERK and increased activity of MMP‐2 and MMP‐9 stimulated with sorafenib. Here, SERPING1 is linked to hepatocellular carcinoma.